Validity of LOCF.pdf
298.81 KB
Z-Score.pdf
69.00 KB
Validation of Quantitative and Qualitative Assays.pdf
988.58 KB
USP Tests.pdf
90.62 KB
Vaccine Clinical Trials.pdf
709.97 KB
Two-Stage Design- Phase II Cancer Clinical Trials.pdf
163.88 KB
Toxicological Studies.pdf
578.03 KB
Trend Estimation.pdf
97.49 KB
Titration Design.pdf
210.33 KB
Testing for Qualitative Interaction.pdf
111.00 KB
Therapeutic Equivalence.pdf
252.46 KB
Survival Analysis.pdf
546.89 KB
Subgroup Analysis.pdf
360.36 KB
Subject-Treatment Interaction.pdf
214.36 KB
Stuart-Maxwell Test.pdf
80.47 KB
Structural Equation Model.pdf
137.69 KB
Statistical Tests for Biomarker Development with Applications to Genetics Data.pdf
119.04 KB
Statistical Process Control.pdf
799.20 KB
Statistical Significance.pdf
222.41 KB
Statistical Principles for Clinical Trials.pdf
202.97 KB
Stability Matrix Designs.pdf
242.36 KB
SROC Curve.pdf
192.28 KB
Stability Analysis for Frozen Drug Products.pdf
217.59 KB
Spatio-Temporal Modeling.pdf
553.61 KB
Specifications.pdf
96.98 KB
Slope Approach for Assessment of Dose Proportionality-Linearity Under a Crossover Design.pdf
643.36 KB
Sequential Estimation for the Additive Hazards Rate Model with Staggered Entry.pdf
87.02 KB
Screening Design.pdf
59.86 KB
Selection of Control in Clinical Trials.pdf
243.43 KB
Sample Size Re-estimation Based on Observed Treatment Difference.pdf
213.11 KB
Sample Size Determination.pdf
657.55 KB
Sample Size Calculation for Survival Data.pdf
301.56 KB
ROC Curve.pdf
654.31 KB
Sample Size Calculation Based on Nonparametric Statistics.pdf
372.40 KB
Robust Analysis for Crossover Design.pdf
583.02 KB
Response Surface Methodology.pdf
976.75 KB
Risk Ratio Analysis.pdf
91.58 KB
Reproductive-Developmental Studies.pdf
342.16 KB
Reliability.pdf
293.19 KB
Reproducibility Probability in Clinical Research.pdf
474.64 KB
Release Targets.pdf
267.56 KB
Randomization.pdf
221.71 KB
Rank Regression in Stability Analysis.pdf
218.93 KB
QT Analysis.pdf
170.37 KB
Proportional Hazards Regression Model.pdf
343.71 KB
Protocol Development.pdf
168.99 KB
Profile Analysis.pdf
212.46 KB
Proportion of Treatment Effect.pdf
87.10 KB
Principal Component Analysis.pdf
125.30 KB
Process Validation.pdf
987.39 KB
Power.pdf
103.80 KB
Prediction Trees.pdf
184.54 KB
Postmarketing Adverse Drug Event Signaling.pdf
618.88 KB
Postmarketing Surveillance.pdf
328.58 KB
Population Bioequivalence.pdf
304.18 KB
Population PK-PD Analysis.pdf
245.11 KB
Phase I Cancer Clinical Trials.pdf
334.99 KB
Placebo Effect.pdf
216.10 KB
Pharmacodynamics with No Covariates.pdf
371.30 KB
Pharmacoeconomics.pdf
0.99 MB
Pharmacodynamic Issues.pdf
348.70 KB
Pharmacodynamics with Covariates.pdf
524.25 KB
Percentile Charts on Correlated Measures.pdf
177.15 KB
Parallel Design.pdf
215.68 KB
Patient Compliance.pdf
245.67 KB
P-Values.pdf
537.72 KB
Outlier Detection in Clinical Research.pdf
558.61 KB
P-Values, Evidence and Multiplicity Considerations for Controlled Clinical Trials.pdf
450.28 KB
Ordered Multiple Class Receiver Operating Characteristic (ROC) Analysis.pdf
139.19 KB
Odds Ratio.pdf
293.18 KB
Onset of Action.pdf
119.93 KB
Noninferiority Analysis in Active Controlled Clinical Trials.pdf
174.94 KB
Multicollinearity.pdf
149.45 KB
Multinational Clinical Trial.pdf
309.03 KB
Modified Large Sample Method.pdf
333.38 KB
Multicenter Trials.pdf
172.03 KB
Mixed Effects Models.pdf
217.62 KB
Missing Values in Repeated Measurement Designs.pdf
127.75 KB
Minimum Effective Dose.pdf
210.44 KB
Microarray Gene Expression.pdf
1.14 MB
Minimization Procedure.pdf
210.44 KB
Meta-Analysis of Therapeutic Trials.pdf
577.69 KB
MedDRA and Its Impact on Pharmaceutical Development.pdf
272.06 KB
Medical Devices.pdf
468.14 KB
McNemar's Test.pdf
85.10 KB
Measuring Agreement.pdf
454.55 KB
Maximum Tolerable Dose for Cancer Chemotherapy.pdf
350.52 KB
Logistic Regression in Three-Point Designs.pdf
145.87 KB
Logistic Regression.pdf
876.71 KB
Lilly Reference Ranges.pdf
563.45 KB
Local Influence Analysis.pdf
76.26 KB
Laboratory Analyses.pdf
313.73 KB
Latent Class Analysis.pdf
155.90 KB
Kullback-Leibler Divergence for Evaluating Equivalence.pdf
230.27 KB
Coefficients in Medical Research.pdf
141.79 KB
Kaplan-Meier Estimator.pdf
589.78 KB
Investigating Quality-of-Life in Clinical Trials.pdf
464.59 KB
International Conference on Harmonization (ICH).pdf
161.68 KB
Interactive Voice Randomization System (IVRS).pdf
649.65 KB
Interim Analysis.pdf
560.78 KB
Intention-to-Treat Analyses (ITT).pdf
171.76 KB
Instrument Development and Validation.pdf
435.58 KB
Integrated Summary Report.pdf
511.41 KB
Individual Bioequivalence.pdf
333.13 KB
In Vitro Micronucleus Test.pdf
606.72 KB
In Vitro Bioequivalence Testing.pdf
300.06 KB
In Vitro Dissolution Profile Comparison.pdf
300.14 KB
Imputation with Item Nonrespondents.pdf
257.67 KB
Imputation in Clinical Research.pdf
177.46 KB
Hypotheses and False Positive Rate in Active Control Non-Inferiority Trials.pdf
302.42 KB
Group Sequential Tests and Variance Heterogeneity in Clinical Trials.pdf
106.64 KB
Good Statistics Practice.pdf
238.62 KB
Group Sequential Methods.pdf
413.00 KB
Good Programming Practice.pdf
275.27 KB
Global Database and System.pdf
319.82 KB
Good Clinical Practice.pdf
276.82 KB
Genetic Linkage and Linkage Disequilibrium Analysis.pdf
353.25 KB
Generalized Estimating Equations (GEE) Method- Sample Size Estimation.pdf
92.11 KB
Generalized Estimating Equation.pdf
178.69 KB
Generalizability Probability in Clinical Research.pdf
178.69 KB
False Discovery Rate (FDR).pdf
310.41 KB
Food and Drug Administration.pdf
302.91 KB
Factorial Designs.pdf
738.42 KB
Failure-Time Model.pdf
155.42 KB
Factor Analysis.pdf
86.11 KB
Exploratory Factor Analysis.pdf
602.15 KB
Extra Variation Models.pdf
925.01 KB
Ethnic Factors.pdf
132.05 KB
Expiration Dating Period.pdf
304.72 KB
Enrichment Design.pdf
138.08 KB
Equivalence Trials.pdf
251.25 KB
Ecologic Inference.pdf
179.99 KB
ED50-ED90.pdf
676.45 KB
Dropout.pdf
250.67 KB
Drug Development.pdf
294.99 KB
Dose Response Study Design.pdf
327.32 KB
Dose Proportionality.pdf
479.72 KB
Dose Response Analysis in Clinical Trials.pdf
245.69 KB
Diagnostic Imaging.pdf
367.55 KB
Data Mining and Biopharmaceutical Research.pdf
461.43 KB
Data Monitoring Committees (DMC).pdf
425.54 KB
Crossover Design.pdf
323.43 KB
Cutoff Designs.pdf
329.96 KB
Cost-Effectiveness Analysis.pdf
247.13 KB
Contract Research Organization (CRO).pdf
204.94 KB
Correlated Probit Model.pdf
115.81 KB
Content Uniformity.pdf
198.67 KB
Confidence Interval and Hypothesis Testing.pdf
187.53 KB
Confounding and Interaction.pdf
284.00 KB
Comparing Variabilities in Clinical Research.pdf
680.57 KB
Combination Drug Clinical Trial.pdf
168.96 KB
Cluster Trials.pdf
173.14 KB
Clustered Study Designs- Power Analysis.pdf
259.29 KB
Clinical Trials.pdf
123.53 KB
Clinical Trial Simulations for Later Development Phases.pdf
123.53 KB
Clinical Trial Simulation.pdf
101.34 KB
Clinical Trial Simulations for Earlier Development Phases.pdf
88.58 KB
Clinical Trial Process.pdf
165.03 KB
Clinical Endpoint.pdf
166.40 KB
Clinical Pharmacology.pdf
131.60 KB
Clinical Data Management.pdf
784.86 KB
Case-Control Studies, Inference in.pdf
200.70 KB
Center Weighting in Multicenter Trials.pdf
118.20 KB
Carry-Forward Analysis.pdf
252.26 KB
Cancer Trials.pdf
324.18 KB
Carcinogenicity Studies of Pharmaceuticals.pdf
505.98 KB
Calibration.pdf
336.89 KB
Bracketing Design.pdf
60.47 KB
Bridging Studies.pdf
213.63 KB
Blinding.pdf
271.45 KB
Bootstrap, The.pdf
265.04 KB
Biologics.pdf
428.00 KB
Biopharmaceutics.pdf
1.10 MB
Bioinformatics.pdf
133.55 KB
Bioassay.pdf
145.55 KB
Bioavailability and Bioequivalence.pdf
255.04 KB
Bayesian Two-Stage Design for Phase II Clinical Trials.pdf
150.68 KB
Bayesian Statistics.pdf
337.79 KB
Bayesian Methods in Meta-Analysis.pdf
98.43 KB
Assay Validation.pdf
420.15 KB
Assay Development.pdf
424.01 KB
Analysis of Variance.pdf
1.63 MB
ANCOVA Approach for Premarketing Shelf Life Determination with Multiple Factors .pdf
72.37 KB
Analysis of Repeated Measures Data with Missing Values- An Overview of Methods .pdf
99.81 KB
Analysis of Heritability.pdf
263.49 KB
Analysis of Clustered Binary Data.pdf
102.37 KB
Analysis of 2 K Tables .pdf
136.80 KB
Ames Test.pdf
406.04 KB
Alpha Spending Function.pdf
106.71 KB
Adverse Event Reporting.pdf
280.19 KB
Adjustment for Covariates.pdf
169.44 KB
Adaptive Dose-Finding Based on Efficacy-Toxicity Trade-Offs .pdf
151.04 KB
Adaptive Designs.pdf
123.36 KB
Active Control Trials.pdf
303.68 KB
Acceptance Sampling.pdf
426.97 KB